Synopsis
In the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand coverage to the rest of India. The price for the drug has been pegged at Rs. 990 for private procurements while for government supply, a subsidized rate will be offered.
Agencies
It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe COVID-19 patients as an adjunct therapy to the existing standard of care.
Drug major Dr Reddy s Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet.
Record Vaccinations May Not Stop a Deadly Third Wave in India
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Record vaccinations may not stop third wave in India | India News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
India s challenges in accelerating its inoculation drive are considerable.
Officials in New Delhi rejoiced earlier this week when India hit a single-day record by administering more than 8 million Covid-19 vaccinations.
But even this unprecedented pace may not be fast enough for a country just emerging from a devastating second wave to head off a third one, experts say. They also question whether this week s push averaging about 4.6 million doses a day, up from about 3 million for most of the past month, can be sustained.
Despite halting all exports in April and benefiting from a huge vaccine producing industry, India has covered only 4% of its vast population, putting it far behind most of the West and China, which is deploying about 20 million doses a day. At this rate, some scientists say a third wave could arrive within months, driving fears the country may see a repeat of the recent nightmare of oxygen shortages and overwhelmed hospitals.